Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11965273 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia
Conditions: Alzheimer Disease;   Vascular Dementia
Intervention: Drug: galantamine hydrobromide

Indicates status has not been verified in more than two years